You have access
Blood Cell Count Biomarkers Predicting Efficacy of Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma
YOSHIFUMI KADONO, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, TAIKI KAMIJIMA, CHIKASHI SETO, AKINOBU TAKANO, SATOSHI YOTSUYANAGI, RYUNOSUKE NAKAGAWA, TOHRU MIYAGI, SHUHEI AOYAMA, HIDEKI ASAHI, RIE FUKUDA and ATSUSHI MIZOKAMI
Anticancer Research March 2021, 41 (3) 1599-1606; DOI: https://doi.org/10.21873/anticanres.14921